Supriya Lifescience Limited (BOM:543434)
India · Delayed Price · Currency is INR 952.15
+50.40 (5.59%)
At close: Jun 4, 2026
Supriya Lifescience Market Cap
Supriya Lifescience has a market cap or net worth of 76.29 billion as of June 5, 2026. Its market cap has increased by 36.08% in one year.
Market Cap
76.29B
Enterprise Value
75.56B
Revenue
8.28B
Ranking
n/a
PE Ratio
36.48
Stock Price
952.15
Market Cap Chart
Since December 28, 2021, Supriya Lifescience's market cap has increased from 31.46B to 76.29B, an increase of 142.54%. That is a compound annual growth rate of 22.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 76.29B | 26.14% |
| Dec 31, 2025 | 60.48B | 1.58% |
| Dec 31, 2024 | 59.54B | 135.04% |
| Dec 29, 2023 | 25.33B | 33.91% |
| Dec 30, 2022 | 18.92B | -51.41% |
| Dec 31, 2021 | 38.93B | 23.76% |
| Dec 28, 2021 | 31.46B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Granules India | 195.66B |
| Caplin Point Laboratories | 154.41B |
| Jubilant Pharmova | 154.19B |
| Viyash Scientific | 111.36B |
| CORONA Remedies | 105.50B |
| Procter & Gamble Health | 102.46B |
| Sanofi India | 73.32B |
| FDC Limited | 61.99B |